Temple University Office of Technology Transfer
This article was originally published in Start Up
Executive SummaryCompanies that approach Temple's tech transfer office often do so to ask what's going on in cancer and cardiovascular disease research; the university has a large heart transplant program, a cancer research institution, and a thrombosis operation. Its research strengths also include drug delivery and pulmonary function.
You may also be interested in...
After emerging from the DOJ settlements, the leading pure-play orthopedics company is emphasizing – and redefining – innovation to drive growth. Zimmer CEO David Dvorak talks to IN VIVO about his company’s commitment to innovation, and how the very notion of innovation is changing.
Because the GE brand is so ubiquitous, visible on everything from household appliances to airplane engines, it’s easy to assume a familiarity with GE and, in particular, with what its health care business is all about. But this interview with John Dineen, President and CEO of GE Healthcare and GE Medical Systems Information Technologies Inc. makes clear that GE’s world view is anything but familiar and stands in striking contrast to that of most other medical technology companies.
Covidien President and CEO Joe Almeida is positioning the company to continue its dynamic growth. Having run up an impressive track record over the past several years, where will – where can-- Covidien go from here?